Results
|
3081.
|
|
|
3082.
|
|
|
3083.
|
|
|
3084.
|
|
|
3085.
|
|
|
3086.
|
|
|
3087.
|
|
|
3088.
|
|
|
3089.
|
|
|
3090.
|
|
|
3091.
|
|
|
3092.
|
|
|
3093.
|
|
|
3094.
|
|
|
3095.
|
|
|
3096.
|
|
|
3097.
|
|
|
3098.
|
Spanish consensus on the use of natalizumab (Tysabri®)-2013. [electronic resource] by
- Fernández, O
- García-Merino, J A
- Arroyo, R
- Álvarez-Cermeño, J C
- Izquierdo, G
- Saiz, A
- Olascoaga, J
- Rodríguez-Antigüedad, A
- Prieto, J M
- Oreja-Guevara, C
- Hernández, M A
- Moral, E
- Meca, J
- Montalbán, X
Producer: 20160418
In:
Neurologia (Barcelona, Spain) vol. 30
Availability: No items available.
|
|
3099.
|
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. [electronic resource] by
- Fredrikson, Sten
- McLeod, Euan
- Henry, Nathaniel
- Pitcher, Ashley
- Lowin, Julia
- Cuche, Matthieu
- Fajutrao, Liberty
- Perard, Rodolphe
- Bates, David
- Chan, Andrew
Producer: 20140219
In:
Journal of medical economics vol. 16
Availability: No items available.
|
|
3100.
|
|